← All organizations

the Chongqing Primary Aldosteronism Study (CONPASS) Group

Academic/Hospital

Also known as: the Chongqing Primary Aldosteronism Study (CONPASS) Group

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 20, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 4 (1 own, 0 via acquisition)

finerenone

Other trials (1 own, 0 via acquisition)

corticotropin

Recent trials (2)

NCT05924620Study chairPhase 4Jun 20, 2023
NCT04461535Study chairN/AJul 31, 2020

Details

Last known activity: Jun 20, 2023